High Tower Advisors, LLC Sangamo Therapeutics, Inc Transaction History

High Tower Advisors, LLC

  • $76.8 Billion
  • Q2 2025

A detailed history of High Tower Advisors, LLC transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 744,768 shares of SGMO stock, worth $387,279. This represents 0.0% of its overall portfolio holdings.

Number of Shares
744,768
Previous 760,663 2.09%
Holding current value
$387,279
Previous $502,000 19.92%
% of portfolio
0.0%
Previous 0.0%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 11, 2025
SELL
$0.43 - $0.81 $6,834 - $12,874
-15,895 Reduced 2.09%
744,768 $402,000
Q1 2025

May 12, 2025
BUY
$0.66 - $1.37 $2,534 - $5,260
3,840 Added 0.51%
760,663 $502,000
Q4 2024

Feb 07, 2025
SELL
$0.78 - $2.87 $28,278 - $104,051
-36,255 Reduced 4.57%
756,823 $771,000
Q3 2024

Nov 14, 2024
BUY
$0.32 - $1.1 $244 - $841
765 Added 0.1%
793,078 $682,000
Q2 2024

Aug 13, 2024
BUY
$0.36 - $0.65 $1,448 - $2,614
4,023 Added 0.51%
792,313 $285,000
Q1 2024

May 06, 2024
SELL
$0.42 - $1.38 $1,226 - $4,029
-2,920 Reduced 0.37%
788,290 $528,000
Q4 2023

Feb 12, 2024
SELL
$0.3 - $0.63 $105,579 - $221,715
-351,930 Reduced 30.79%
791,210 $427,000
Q3 2023

Nov 08, 2023
SELL
$0.58 - $1.47 $7,960 - $20,175
-13,725 Reduced 1.19%
1,143,140 $685,000
Q2 2023

Aug 14, 2023
BUY
$1.11 - $1.74 $139,563 - $218,775
125,733 Added 12.19%
1,156,865 $1.5 Million
Q1 2023

May 11, 2023
BUY
$1.66 - $3.67 $288 - $638
174 Added 0.02%
1,031,132 $1.81 Million
Q4 2022

Feb 08, 2023
SELL
$2.77 - $5.07 $362,778 - $664,002
-130,967 Reduced 11.27%
1,030,958 $3.24 Million
Q3 2022

Nov 09, 2022
SELL
$4.27 - $6.39 $23,946 - $35,835
-5,608 Reduced 0.48%
1,161,925 $5.64 Million
Q2 2022

Aug 10, 2022
BUY
$3.28 - $6.21 $354,292 - $670,779
108,016 Added 10.19%
1,167,533 $4.79 Million
Q1 2022

May 12, 2022
BUY
$5.23 - $7.82 $605,116 - $904,781
115,701 Added 12.26%
1,059,517 $6.17 Million
Q4 2021

Feb 10, 2022
BUY
$7.29 - $10.97 $6.66 Million - $10 Million
913,600 Added 3023.56%
943,816 $7.14 Million
Q3 2021

Nov 12, 2021
SELL
$9.01 - $12.01 $45,770 - $61,010
-5,080 Reduced 14.39%
30,216 $274,000
Q2 2021

Aug 06, 2021
BUY
$10.17 - $12.64 $18,865 - $23,447
1,855 Added 5.55%
35,296 $421,000
Q1 2021

May 10, 2021
SELL
$10.88 - $17.05 $38,558 - $60,425
-3,544 Reduced 9.58%
33,441 $418,000
Q4 2020

Feb 10, 2021
SELL
$9.23 - $18.18 $16,152 - $31,815
-1,750 Reduced 4.52%
36,985 $578,000
Q3 2020

Nov 13, 2020
SELL
$9.38 - $12.48 $18,722 - $24,910
-1,996 Reduced 4.9%
38,735 $368,000
Q2 2020

Aug 10, 2020
SELL
$6.21 - $11.83 $16,406 - $31,254
-2,642 Reduced 6.09%
40,731 $364,000
Q1 2020

May 21, 2020
BUY
$5.05 - $8.85 $30,158 - $52,852
5,972 Added 15.97%
43,373 $279,000
Q4 2019

Feb 14, 2020
SELL
$8.03 - $11.7 $129,885 - $189,247
-16,175 Reduced 30.19%
37,401 $313,000
Q3 2019

Nov 12, 2019
BUY
$9.05 - $12.22 $44,535 - $60,134
4,921 Added 10.11%
53,576 $485,000
Q2 2019

Aug 13, 2019
BUY
$8.75 - $13.03 $17,937 - $26,711
2,050 Added 4.4%
48,655 $523,000
Q1 2019

May 15, 2019
SELL
$7.72 - $12.81 $176,872 - $293,489
-22,911 Reduced 32.96%
46,605 $445,000
Q4 2018

Feb 14, 2019
SELL
$9.51 - $16.6 $216,828 - $378,480
-22,800 Reduced 24.7%
69,516 $792,000
Q3 2018

Nov 09, 2018
BUY
$13.05 - $19.05 $890,806 - $1.3 Million
68,261 Added 283.77%
92,316 $1.55 Million
Q2 2018

Aug 14, 2018
BUY
$13.9 - $19.8 $161,935 - $230,670
11,650 Added 93.91%
24,055 $341,000
Q1 2018

May 15, 2018
BUY
$16.7 - $26.35 $1,670 - $2,635
100 Added 0.81%
12,405 $237,000
Q4 2017

Feb 14, 2018
SELL
$11.6 - $17.35 $9,280 - $13,880
-800 Reduced 6.1%
12,305 $201,000
Q3 2017

Nov 14, 2017
SELL
$8.4 - $15.0 $136,920 - $244,500
-16,300 Reduced 55.43%
13,105 $198,000
Q2 2017

Aug 14, 2017
BUY
N/A
29,405
29,405 $259,000

Others Institutions Holding SGMO

# of Institutions
126
Shares Held
50.6M
Call Options Held
1.13M
Put Options Held
820K
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $81.4M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email